Nuclear receptors and chromatin: An inducible couple

Journal of Molecular Endocrinology

Volumn 52, Issue 2, 2013, Pages

  Gadaleta, Raffaella Maria ^a   Magnani, Luca ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chromatin; Epigenetics; Gene expression; Nuclear receptors; Oestrogen receptors

Indexed keywords

CHROMATIN; EPIGENETICS; GENE EXPRESSION; NUCLEAR RECEPTORS; OESTROGEN RECEPTORS;

ANIMALS; CHROMATIN; EPIGENESIS, GENETIC; GENOME; HISTONES; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, UNTRANSLATED;

EID: 84893980123     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0170     Document Type: Review

References (124)

1. Ali S, Buluwela L & Coombes RC 2011 Antiestrogens and their therapeutic applications in breast cancer and other diseases. Annual Review of Medicine 62 217-232. (doi:10.1146/annurev-med-052209-100305)
2. Ananthanarayanan M, Li S, Balasubramaniyan N, Suchy FJ & Walsh MJ 2004 Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1. Journal of Biological Chemistry 279 54348-54357. (doi:10.1074/jbc.M410021200)
3. Andreu-Vieyra C, Lai J, Berman BP, Frenkel B, Jia L, Jones PA & Coetzee GA 2011 Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Molecular and Cellular Biology 31 4648-4662. (doi:10.1128/MCB.05934-11)
4. Bain DL, Heneghan AF, Connaghan-Jones KD & Miura MT 2007 Nuclear receptor structure: implications for function. Annual Review of Physiology 69 201-220. (doi:10.1146/annurev.physiol.69.031905. 160308)
5. Balasubramaniyan N, Ananthanarayanan M & Suchy FJ 2012 Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes. American Journal of Physiology. Gastrointestinal and Liver Physiology 302 G937-G947. (doi:10.1152/ ajpgi.00441.2011)
6. Belandia B, Orford RL, Hurst HC & Parker MG 2002 Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO Journal 21 4094-4103. (doi:10.1093/emboj/cdf412)
7. Berkes CA, Bergstrom DA, Penn BH, Seaver KJ, Knoepfler PS & Tapscott SJ 2004 Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Molecular Cell 14 465-477. (doi:10.1016/S1097-2765(04)00260-6)
8. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K et al. 2006 A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 315-326. (doi:10.1016/j.cell.2006.02.041)
9. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H & Yamamoto KR 2007 Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes and Development 21 2005-2017. (doi:10.1101/ gad.1564207)
10. Bourguet W, Germain P & Gronemeyer H 2000 Nuclear receptor ligandbinding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends in Pharmacological Sciences 21 381-388. (doi:10.1016/S0165-6147(00)01548-0)
11. Calabrese JM, Sun W, Song L, Mugford JW, Williams L, Yee D, Starmer J, Mieczkowski P, Crawford GE & Magnuson T 2012 Site-specific silencing of regulatory elements as a mechanism of X inactivation. Cell 151 951-963. (doi:10.1016/j.cell.2012.10.037)
12. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR et al. 2005 Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 33-43. (doi:10.1016/ j.cell.2005.05.008)
13. Chambon P 2005 The nuclear receptor superfamily: a personal retrospect on the first two decades. Molecular Endocrinology 19 1418-1428. (doi:10.1210/me.2005-0125)
14. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK et al. 2001 A PPAR g-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular Cell 7 161-171. (doi:10.1016/S1097-2765 (01)00164-2)
15. Chen D, Pace PE, Coombes RC & Ali S 1999 Phosphorylation of human estrogen receptor a by protein kinase A regulates dimerization. Molecular and Cellular Biology 19 1002-1015.
16. Chong HK, Infante AM, Seo Y-K, Jeon T-I, Zhang Y, Edwards PA, Xie X & Osborne TF 2010 Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. Nucleic Acids Research 38 6007-6017. (doi:10.1093/nar/gkq397)
17. Christophersen NS & Helin K 2010 Epigenetic control of embryonic stem cell fate. Journal of Experimental Medicine 207 2287-2295. (doi:10.1084/ jem.20101438)
18. Cirillo LA & Zaret KS 1999 An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Molecular Cell 4 961-969. (doi:10.1016/S1097-2765 (00)80225-7)
19. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, et al. 2007 Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 799-816. (doi:10.1038/nature05874)
20. ENCODE Project Consortium, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C & Snyder M 2012 An integrated encyclopedia of DNA elements in the human genome. Nature 489 57-74. (doi:10.1038/ nature11247)
21. Ernst J & Kellis M 2010 Discovery and characterization of chromatin states for systematic annotation of the human genome. Nature Biotechnology 28 817-825. (doi:10.1038/nbt.1662)
22. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M et al. 2011 Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473 43-49. (doi:10.1038/nature09906)
23. Evans RM 2005 The nuclear receptor superfamily: a rosetta stone for physiology. Molecular Endocrinology 19 1429-1438. (doi:10.1210/me. 2005-0046)
24. Fang S, Tsang S, Jones R, Ponugoti B, Yoon H, Wu S-Y, Chiang C-M, Willson TM & Kemper JK 2008 The p300 acetylase is critical for ligandactivated farnesoid X receptor (FXR) induction of SHP. Journal of Biological Chemistry 283 35086-35095. (doi:10.1074/jbc.M803531200)
25. Fondell JD, Ge H & Roeder RG 1996 Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. PNAS 93 8329-8333. (doi:10.1073/pnas.93.16.8329)
26. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, et al. 2009 An oestrogen-receptor-a-bound human chromatin interactome. Nature 462 58-64. (doi:10.1038/nature08497)
27. Germain P, Staels B, Dacquet C, Spedding M & Laudet V 2006 Overview of nomenclature of nuclear receptors. Pharmacological Reviews 58 685-704. (doi:10.1124/pr.58.4.2)
28. Giguère V, Hollenberg SM, Rosenfeld MG & Evans RM 1986 Functional domains of the human glucocorticoid receptor. Cell 46 645-652. (doi:10.1016/0092-8674(86)90339-9)
29. Gineste R, Sirvent A, Paumelle R, Helleboid S, Aquilina A, Darteil R, Hum DW, Fruchart J-C & Staels B 2008 Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Molecular Endocrinology 22 2433-2447. (doi:10.1210/me.2008-0092)
30. Giresi PG, Kim J, McDaniell RM, Iyer VR & Lieb JD 2007 FAIRE (formaldehyde-assisted isolation of regulatory elements) isolates active regulatory elements from human chromatin. Genome Research 17 877-885. (doi:10.1101/gr.5533506)
31. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y & Shine J 1986 Sequence and expression of human estrogen receptor complementary DNA. Science 231 1150-1154. (doi:10.1126/science.3753802)
32. Gronemeyer H, Gustafsson J-A & Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nature Reviews. Drug Discovery 3 950-964. (doi:10.1038/nrd1551)
33. Grøntved L & Hager GL 2012 Impact of chromatin structure on PR signaling: transition from local to global analysis. Molecular and Cellular Endocrinology 357 30-36. (doi:10.1016/j.mce.2011.09.006)
34. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai M-C, Hung T, Argani P, Rinn JL et al. 2010 Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464 1071-1076. (doi:10.1038/nature08975)
35. Hah N, Murakami S, Nagari A, Danko CG & Kraus WL 2013 Enhancer transcripts mark active estrogen receptor binding sites. Genome Research 23 1210-1223. (doi:10.1101/gr.152306.112)
36. He HH, Meyer CA, Chen MW, Jordan VC, Brown M & Liu XS 2012 Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Research 22 1015-1025. (doi:10.1101/ gr.133280.111)
37. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H & Glass CK 2010 Simple combinations of lineagedetermining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular Cell 38 576-589. (doi:10.1016/j.molcel.2010.05.004)
38. Heldring N, Isaacs GD, Diehl AG, Sun M, Cheung E, Ranish JA & Kraus WL 2011 Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Molecular Endocrinology 25 564-574. (doi:10.1210/me.2010-0425)
39. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG & Evans RM 1985 Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 635-641. (doi:10.1038/318635a0)
40. Hu Q, Kwon Y-S, Nunez E, Cardamone MD, Hutt KR, Ohgi KA, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG et al. 2008 Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. PNAS 105 19199-19204. (doi:10.1073/pnas.0810634105)
41. Hua S, Kittler R & White KP 2009 Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137 1259-1271. (doi:10.1016/j.cell.2009.04.043)
42. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D & Carroll JS 2010 FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nature Genetics 43 27-33. (doi:10.1038/ng.730)
43. Ito K, Barnes PJ & Adcock IM 2000 Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1b-induced histone H4 acetylation on lysines 8 and 12. Molecular and Cellular Biology 20 6891-6903. (doi:10.1128/MCB.20.18.6891-6903.2000)
44. Jeong KW, Lee Y-H & Stallcup MR 2009 Recruitment of the SWI/SNF chromatin remodeling complex to steroid hormone-regulated promoters by nuclear receptor coactivator flightless-I. Journal of Biological Chemistry 284 29298-29309. (doi:10.1074/jbc.M109.037010)
45. Jin C, Zang C, Wei G, Cui K, Peng W, Zhao K & Felsenfeld G 2009 H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome- free regions' of active promoters and other regulatory regions. Nature Genetics 41 941-945. (doi:10.1038/ng.409)
46. John S, Sabo PJ, Johnson TA, Sung M-H, Biddie SC, Lightman SL, Voss TC, Davis SR, Meltzer PS, Stamatoyannopoulos JA et al. 2008 Interaction of the glucocorticoid receptor with the chromatin landscape. Molecular Cell 29 611-624. (doi:10.1016/j.molcel.2008.02.010)
47. Jordan VC 2003 Tamoxifen: a most unlikely pioneering medicine. Nature Reviews. Drug Discovery 2 205-213. (doi:10.1038/nrd1031)
48. Joseph R, Orlov YL, Huss M, Sun W, Kong SL, Ukil L, Pan YF, Li G, Lim M, Thomsen JS et al. 2010 Integrative model of genomic factors for determining binding site selection by estrogen receptor-a. Molecular Systems Biology 6 456. (doi:10.1038/msb.2010.109)
49. Jozwik KM & Carroll JS 2012 Pioneer factors in hormone-dependent cancers. Nature Reviews. Cancer 12 381-385. (doi:10.1038/nrc3263)
50. Kasowski M, Kyriazopoulou-Panagiotopoulou S, Grubert F, Zaugg JB, Kundaje A, Liu Y, Boyle AP, Zhang QC, Zakharia F, Spacek DV et al. 2013 Extensive variation in chromatin states across humans. Science 342 750-752. (doi:10.1126/science.1242510)
51. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H et al. 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 1491-1494. (doi:10.1126/science.270.5241. 1491)
52. Kim T-K, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S et al. 2010 Widespread transcription at neuronal activity-regulated enhancers. Nature 465 182-187. (doi:10.1038/nature09033)
53. King HA, Trotter KW & Archer TK 2012 Chromatin remodeling during glucocorticoid receptor regulated transactivation. Biochimica et Biophysica Acta 1819 716-726. (doi:10.1016/j.bbagrm.2012.02.019)
54. Kininis M & Kraus WL 2008 A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nuclear Receptor Signaling 6 e005.
55. Kittler R, Zhou J, Hua S, Ma L, Liu Y, Pendleton E, Cheng C, Gerstein M & White KP 2013 A comprehensive nuclear receptor network for breast cancer cells. Cell Reports 3 538-551. (doi:10.1016/j.celrep.2013.01.004)
56. Kliewer SA & Willson TM 2002 Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. Journal of Lipid Research 43 359-364.
57. Ko S, Ahn J, Song CS, Kim S, Knapczyk-Stwora K & Chatterjee B 2011 Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Molecular Endocrinology 25 433-444. (doi:10.1210/ me.2010-0482)
58. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S et al. 2011 Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Research 71 6320-6326. (doi:10.1158/0008-5472.CAN-11-1021)
59. Kouzarides T 2007 Chromatin modifications and their function. Cell 128 693-705. (doi:10.1016/j.cell.2007.02.005)
60. Krasowski MD, Ni A, Hagey LR & Ekins S 2011 Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR. Molecular and Cellular Endocrinology 334 39-48. (doi:10.1016/j.mce.2010.06.016)
61. Kraus WL & Kadonaga JT, 1998 p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes and Development 12 331-342. (doi:10.1101/gad. 12.3.331)
62. Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS & Brown M 2008 Unique ERa cistromes control cell type-specific gene regulation. Molecular Endocrinology 22 2393-2406. (doi:10.1210/me. 2008-0100)
63. Lai C-F, Flach KD, Alexi X, Fox SP, Ottaviani S, Thiruchelvam PTR, Kyle FJ, Thomas RS, Launchbury R, Hua H et al. 2013 Co-regulated gene expression by oestrogen receptor a and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. Nucleic Acids Research 41 10228-10240. (doi:10.1093/nar/gkt827)
64. Lam MTY, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y, Benner C, Kaikkonen MU, Kim AS, Kosaka M, et al. 2013 Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498 511-515. (doi:10.1038/nature12209)
65. Lee Y-H, Coonrod SA, Kraus WL, Jelinek MA & Stallcup MR 2005 Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. PNAS 102 3611-3616. (doi:10.1073/pnas.0407159102)
66. Lee J, Seok S, Yu P, Kim K, Smith Z, Rivas-Astroza M, Zhong S & Kemper JK 2012 Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice. Hepatology 56 108-117. (doi:10.1002/ hep.25609)
67. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, Feng D, Zhuo D, Stoeckert CJ, Liu XS et al. 2008 PPARg and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes and Development 22 2941-2952. (doi:10.1101/gad.1709008)
68. Li G, Ruan X, Auerbach RK, Sandhu KS, Zheng M, Wang P, Poh HM, Goh Y, Lim J, Zhang J et al. 2012 Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148 84-98. (doi:10.1016/j.cell.2011.12.014)
69. Li W, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY, Merkurjev D, Zhang J, Ohgi K, Song X et al. 2013 Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498 516-520. (doi:10.1038/nature12210)
70. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS & Brown M 2008 FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132 958-970. (doi:10.1016/j.cell.2008.01.018)
71. Lupien M, Meyer CA, Bailey ST, Eeckhoute J, Cook J, Westerling T, Zhang X, Carroll JS, Rhodes DR, Liu XS et al. 2010 Growth factor stimulation induces a distinct ER(a) cistrome underlying breast cancer endocrine resistance. Genes and Development 24 2219-2227. (doi:10.1101/gad. 1944810)
72. Magnani L & Lupien M 2013 Chromatin and epigenetic determinants of estrogen receptor a (ESR1) signaling. Molecular and Cellular Endocrinology 382 633-641. (doi:10.1016/j.mce.2013.04.026)
73. Magnani L, Ballantyne EB, Zhang X & Lupien M 2011a PBX1 genomic pioneer function drives ERa signaling underlying progression in breast cancer. PLoS Genetics 7 e1002368. (doi:10.1371/journal.pgen. 1002368)
74. Magnani L, Eeckhoute J & Lupien M 2011b Pioneer factors: directing transcriptional regulators within the chromatin environment. Trends in Genetics 27 465-474. (doi:10.1016/j.tig.2011.07.002)
75. Mangelsdorf DJ & Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83 841-850. (doi:10.1016/0092-8674(95)90200-7)
76. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et al. 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839. (doi:10. 1016/0092-8674(95)90199-X)
77. Métivier R, Penot G, Hübner MR, Reid G, Brand H, Kos M & Gannon F 2003 Estrogen receptor-a directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 751-763. (doi:10.1016/S0092-8674(03)00934-6)
78. Métivier R, Gallais R, Tiffoche C, Le Péron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G et al. 2008 Cyclical DNA methylation of a transcriptionally active promoter. Nature 452 45-50. (doi:10.1038/nature06544)
79. Miao J, Fang S, Lee J, Comstock C, Knudsen KE & Kemper JK 2009 Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis. Molecular and Cellular Biology 29 6170-6181. (doi:10.1128/MCB.00825-09)
80. Miranda TB, Voss TC, Sung M-H, Baek S, John S, Hawkins M, Grøntved L, Schiltz RL & Hager GL 2013 Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level. Cancer Research 73 5130-5139. (doi:10.1158/0008-5472.CAN- 13-0742)
81. Mohammed H, D'Santos C, Sérandour AA, Ali HR, Brown GD, Atkins A, Rueda OM, Holmes KA, Theodorou V, Robinson JLL et al. 2013 Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Reports 3 342-349. (doi:10.1016/j.celrep.2013. 01.010)
82. Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, Børgesen M, Francoijs K-J, Mandrup S et al. 2008 Genomewide profiling of PPARg:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes and Development 22 2953-2967. (doi:10.1101/gad.501108)
83. Nuclear Receptors Nomenclature Committee 1999 A unified nomenclature system for the nuclear receptor superfamily. Cell 97 161-163. (doi:10.1016/S0092-8674(00)80726-6)
84. O'Malley BW & Kumar R 2009 Nuclear receptor coregulators in cancer biology. Cancer Research 69 8217-8222. (doi:10.1158/0008-5472. CAN-09-2223)
85. Orom UA & Shiekhattar R 2011 Long non-coding RNAs and enhancers. Current Opinion in Genetics & Development 21 194-198. (doi:10.1016/ j.gde.2011.01.020)
86. Overington JP, Al-Lazikani B & Hopkins AL 2006 How many drug targets are there? Nature Reviews. Drug Discovery 5 993-996. (doi:10.1038/ nrd2199)
87. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG & Glass CK 2005 A SUMOylationdependent pathway mediates transrepression of inflammatory response genes by PPAR-g. Nature 437 759-763. (doi:10.1038/ nature03988)
88. Perillo B, Ombra MN, Bertoni A, Cuozzo C, Sacchetti S, Sasso A, Chiariotti L, Malorni A, Abbondanza C & Avvedimento EV, 2008 DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319 202-206. (doi:10.1126/science.1147674)
89. Pfitzner E, Jähne R, Wissler M, Stoecklin E & Groner B, 1998 p300/CREBbinding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Molecular Endocrinology 12 1582-1593. (doi:10.1210/me.12.10.1582)
90. Qiu Y, Stavreva DA, Luo Y, Indrawan A, Chang M & Hager GL 2011 Dynamic interaction of HDAC1 with a glucocorticoid receptorregulated gene is modulated by the activity state of the promoter. Journal of Biological Chemistry 286 7641-7647. (doi:10.1074/jbc.M110. 185488)
91. Reid G, Hübner MR, Métivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J & Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERa on responsive promoters is an integral feature of estrogen signaling. Molecular Cell 11 695-707. (doi:10.1016/ S1097-2765(03)00090-X)
92. Rizzo G, Renga B, Antonelli E, Passeri D, Pellicciari R & Fiorucci S 2005 The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. Molecular Pharmacology 68 551-558. (doi:10.1124/mol.105.012104)
93. Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR et al. 2012 Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481 389-393.
94. Sap J, Muñoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H & Vennström B 1986 The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324 635-640. (doi:10.1038/324635a0)
95. Shang Y & Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295 2465-2468. (doi:10.1126/science.1068537)
96. Srinivasan S, Nwachukwu JC, Parent AA, Cavett V, Nowak J, Hughes TS, Kojetin DJ, Katzenellenbogen JA & Nettles KW 2013 Ligand-binding dynamics rewire cellular signaling via estrogen receptor-a. Nature Chemical Biology 9 326-332. (doi:10.1038/nchembio.1214)
97. Stender JD, Kim K, Charn TH, Komm B, Chang KCN, Kraus WL, Benner C, Glass CK & Katzenellenbogen BS 2010 Genome-wide analysis of estrogen receptor a DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Molecular and Cellular Biology 30 3943-3955. (doi:10.1128/ MCB.00118-10)
98. Stratmann M & Schibler U 2011 Transcription factor loading: please take my place! Cell 146 497-499. (doi:10.1016/j.cell.2011.07.037)
99. Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D, Peng J, Cheng X & Vertino PM 2008 Regulation of estrogen receptor a by the SET7 lysine methyltransferase. Molecular Cell 30 336-347. (doi:10.1016/j.molcel.2008.03.022)
100. Suganuma T & Workman JL 2008 Crosstalk among histone modifications. Cell 135 604-607. (doi:10.1016/j.cell.2008.10.036)
101. Tateishi K, Okada Y, Kallin EM & Zhang Y 2009 Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458 757-761. (doi:10.1038/nature07777)
102. Tewari AK, Yardimci GG, Shibata Y, Sheffield NC, Song L, Taylor BS, Georgiev SG, Coetzee GA, Ohler U, Furey TS et al. 2012 Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity. Genome Biology 13 R88. (doi:10.1186/ gb-2012-13-10-r88)
103. Thomas AM, Hart SN, Kong B, Fang J, Zhong X-B & Guo GL 2010 Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology 51 1410-1419. (doi:10.1002/hep.23450)
104. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B et al. 2012 The accessible chromatin landscape of the human genome. Nature 489 75-82. (doi:10.1038/nature11232)
105. Trotter KW & Archer TK 2008 The BRG1 transcriptional coregulator. Nuclear Receptor Signaling 6 e004.
106. Tsai M-C, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E & Chang HY 2010 Long noncoding RNA as modular scaffold of histone modification complexes. Science 329 689-693. (doi:10.1126/ science.1192002)
107. Tzagarakis-Foster C & Privalsky ML 1998 Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. Journal of Biological Chemistry 273 10926-10932. (doi:10.1074/jbc.273.18.10926)
108. Vavassori P, Mencarelli A, Renga B, Distrutti E & Fiorucci S 2009 The bile acid receptor FXR is a modulator of intestinal innate immunity. Journal of Immunology 183 6251-6261. (doi:10.4049/jimmunol. 0803978)
109. Vicent GP, Nacht AS, Font-Mateu J, Castellano G, Gaveglia L, Ballaré C & Beato M 2011 Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. Genes and Development 25 845-862. (doi:10.1101/gad.621811)
110. Vicent GP, Nacht AS, Zaurin R, Font-Mateu J, Soronellas D, Le Dily F, Reyes D & Beato M 2013 Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes. Genes and Development 27 1179-1197. (doi:10.1101/gad.215293.113)
111. Voss TC, Schiltz RL, Sung M-H, Yen PM, Stamatoyannopoulos JA, Biddie SC, Johnson TA, Miranda TB, John S & Hager GL 2011 Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell 146 544-554. (doi:10.1016/j.cell. 2011.07.006)
112. Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G & WaterfieldM1985 Cloning of the human estrogen receptor cDNA. PNAS 82 7889-7893. (doi:10.1073/pnas.82.23.7889)
113. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M et al. 2009 Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138 245-256. (doi:10.1016/j.cell.2009.04.056)
114. Wärnmark A, Treuter E, Wright APH & Gustafsson J-A 2003 Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Molecular Endocrinology 17 1901-1909. (doi:10.1210/me.2002-0384)
115. Welboren W-J, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FC, Span PN & Stunnenberg HG 2009 ChIP-Seq of ERa and RNA polymerase II defines genes differentially responding to ligands. EMBO Journal 28 1418-1428. (doi:10.1038/emboj.2009.88)
116. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI & Young RA 2013 Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153 307-319. (doi:10.1016/j.cell.2013.03.035)
117. Willis S & Griffin PR 2011 Mutual information identifies sequence positions conserved within the nuclear receptor superfamily: approach reveals functionally important regions for DNA binding specificity. Nuclear Receptor Signaling 9 e001.
118. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA & Mangelsdorf DJ 1995 LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes and Development 9 1033-1045. (doi:10.1101/gad.9.9. 1033)
119. Wu Y, Chin WW, Wang Y & Burris TP 2003 Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor g. Journal of Biological Chemistry 278 8637-8644. (doi:10.1074/jbc.M210910200)
120. Yamane K, Toumazou C, Tsukada Y-I, Erdjument-Bromage H, Tempst P, Wong J & Zhang Y 2006 JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125 483-495. (doi:10.1016/j.cell.2006.03.027)
121. Zaret KS & Carroll JS 2011 Pioneer transcription factors: establishing competence for gene expression. Genes and Development 25 2227-2241. (doi:10.1101/gad.176826.111)
122. Zaret KS, Watts J, Xu J, Wandzioch E, Smale ST & Sekiya T 2008 Pioneer factors, genetic competence, and inductive signaling: programming liver and pancreas progenitors from the endoderm. Cold Spring Harbor Symposia on Quantitative Biology 73 119-126. (doi:10.1101/sqb. 2008.73.040)
123. Zechel C, Shen XQ, Chambon P & Gronemeyer H 1994 Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO Journal 13 1414-1424.
124. Zhu J, Adli M, Zou JY, Verstappen G, Coyne M, Zhang X, Durham T, Miri M, Deshpande V, De Jager PL et al. 2013 Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152 642-654. (doi:10.1016/j.cell.2012.12.033)